Literature DB >> 24824099

Dedicated orthopaedic operating rooms: beneficial to patients and providers alike.

Timothy T Roberts1, Maria Vanushkina, Siddharth Khasnavis, James Snyder, Dean N Papaliodis, Andrew J Rosenbaum, Richard L Uhl, Jared T Roberts, Kaushik Bagchi.   

Abstract

OBJECTIVE: Dedicated orthopaedic operating rooms (DOORs) are increasingly popular solutions to reducing after-hours procedures, physician fatigue, and elective schedule disruptions. Although the benefits to surgeons are well understood, there are comparatively few studies that explore the effects of DOORs on patient care. We compared treatments and outcomes for all consecutive patients with femoral neck fractures, 4 years before and 4 years after implementation of a DOOR-based schedule.
DESIGN: Retrospective case-control study.
SETTING: Level 1 academic trauma center. PATIENTS: A total of 111 consecutive trauma patients undergoing surgical management of isolated OTA group 31-B femoral neck fractures. INTERVENTION: Based on individual patient factors and fracture characteristics, patients were managed with either hemiarthroplasty or open reduction internal fixation (ORIF). MAIN OUTCOME MEASURES: Surgical timing, intervention type, perioperative complications, and postoperative length of stay.
RESULTS: Retrospective analysis revealed a significant decrease in after-hour surgery (4 PM-7:30 AM) for all femoral neck fractures (66.7%-19.3%; P < 0.001). No significant differences were found between the rates of arthroplasty versus those of open reduction internal fixation. Patients undergoing surgical treatment for femoral neck fractures after DOOR suffered significantly fewer morbidities, including significantly decreased rates of postoperative intensive care unit admissions, stroke, infections, and myocardial infarction or congestive heart failure exacerbations. We also observed a significant decrease in postoperative mortality (5.6% pre-DOOR vs. 0% post-DOOR; P = 0.04). Patients undergoing hemiarthroplasty experienced a significant shorter hospitalization (14.5 days pre-DOOR vs. 9.9 days post-DOOR; P = 0.04).
CONCLUSIONS: In our experience, a weekday DOOR is closely associated with improvements in both patient safety and outcomes. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2015        PMID: 24824099     DOI: 10.1097/BOT.0000000000000154

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  5 in total

1.  'After-hours' non-elective spine surgery is associated with increased perioperative adverse events in a quaternary center.

Authors:  Raphaële Charest-Morin; Alana M Flexman; Michael Bond; Tamir Ailon; Nicolas Dea; Marcel Dvorak; Brian Kwon; Scott Paquette; Charles G Fisher; John Street
Journal:  Eur Spine J       Date:  2018-12-06       Impact factor: 3.134

2.  After hours surgery and mortality: the potential role of acute care surgery models as a factor accounting for results.

Authors:  David R Lardner; Carmen A Brauer; A Rob Harrop; Ali MacRobie
Journal:  CMAJ       Date:  2017-02-06       Impact factor: 8.262

3.  Operational strategies to manage non-elective orthopaedic surgical flows: a simulation modelling study.

Authors:  Marie Persson; Helena Hvitfeldt-Forsberg; Maria Unbeck; Olof Gustaf Sköldenberg; Andreas Stark; Paula Kelly-Pettersson; Pamela Mazzocato
Journal:  BMJ Open       Date:  2017-04-07       Impact factor: 2.692

4.  The Correlation Between Timing of Surgery and the Need for RBC Transfusions in the Geriatric Intertrochanteric Fracture Population.

Authors:  Yun-Fa Yang; Jian-Wen Huang; Xiao-Sheng Gao; Zai-Li Liu; Jian-Wei Wang; Zhong-He Xu
Journal:  Geriatr Orthop Surg Rehabil       Date:  2021-02-27

5.  Hospital variation in allogeneic transfusion and extended length of stay in primary elective hip and knee arthroplasty: a cross-sectional study.

Authors:  Veronique M A Voorn; Perla J Marang-van de Mheen; Anja van der Hout; Cynthia So-Osman; M Elske van den Akker-van Marle; Ankie W M M Koopman-van Gemert; Albert Dahan; Thea P M Vliet Vlieland; Rob G H H Nelissen; Leti van Bodegom-Vos
Journal:  BMJ Open       Date:  2017-07-20       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.